Targeting Mitochondrial Metabolic Dysfunction in Pulmonary Hypertension: Toward New Therapeutic Approaches?

Pulmonary arterial hypertension (PAH) is a rare disease characterized by pulmonary vascular remodeling leading to right heart failure and death. To date, despite the three therapeutic approaches targeting the three major endothelial dysfunction pathways based on the prostacyclin, nitric oxide/cyclic...

Descripción completa

Detalles Bibliográficos
Autores principales: Riou, Marianne, Enache, Irina, Sauer, François, Charles, Anne-Laure, Geny, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253387/
https://www.ncbi.nlm.nih.gov/pubmed/37298522
http://dx.doi.org/10.3390/ijms24119572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253387/
https://www.ncbi.nlm.nih.gov/pubmed/37298522
http://dx.doi.org/10.3390/ijms24119572

Ejemplares similares